Back

Prognostic impact of proton pump inhibitors in patients after elective percutaneous coronary intervention with implantation of second-generation drug eluting stents

11 April 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Cardiovascular Pharmacotherapy Cardiovascular Pharmacotherapy EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Olga Shahmatova

National Medical Research Center of Cardiology, Moscow (Russian Federation)

13 More presentations in this session

Presentation thumbnail
A novel direct method to evaluate adherence to atorvastatin therapy in coronary prevention - Cut-off values generated in a clinical non-adherence study
Doctor O. Kristiansen (Drammen, NO)
Abstract
Presentation thumbnail
The relationship of drug treatment safety parameters and adherence to pharmacotherapy in patients with cardiovascular diseases (according to the data of the outpatient registry)
Doctor Y. Lukina (Moscow, RU)
Abstract
Presentation thumbnail
Focus-group as a qualitative method for study of compliance in cardiovascular disease patients and their doctors
Doctor O. Semenova (Saratov, RU)
Abstract
Presentation thumbnail
Adherence to long-term treatment and some traits of patients and their doctors: a prospective study of treatment compliance in patients with cardiovascular diseases
Doctor Y. Bulaeva (Saratov, RU)
Presentation thumbnail
The impact of anaemia and intravenous iron replacement therapy on exercise capacity in patients after cardiac surgery.
Doctor C. Nugara (Palermo, IT)

Access the full session

Session thumbnail
Poster Session 1 - Cardiovascular Pharmacotherapy

The Event

Event poster

EuroPrevent 2019

11 April - 13 April 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources